-
1
-
-
0030777012
-
The capsaicin receptor: A heat-activated ion channel in the pain pathway
-
DOI 10.1038/39807
-
Caterina MJ, Schumacher MA, Tominaga M, et al. The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature 1997;389:816-24 (Pubitemid 27462969)
-
(1997)
Nature
, vol.389
, Issue.6653
, pp. 816-824
-
-
Caterina, M.J.1
Schumacher, M.A.2
Tominaga, M.3
Rosen, T.A.4
Levine, J.D.5
Julius, D.6
-
2
-
-
34248138496
-
The vanilloid receptor TRPV1: 10 years from channel cloning to antagonist proof-of-concept
-
DOI 10.1038/nrd2280, PII NRD2280
-
Szallasi A, Cortright DN, Blum CA, Eid SR. The vanilloid receptor TRPV1: 10 years from channel cloning to antagonist proof-of-concept. Nat Rev Drug Discov 2007;6:357-72 (Pubitemid 46705200)
-
(2007)
Nature Reviews Drug Discovery
, vol.6
, Issue.5
, pp. 357-372
-
-
Szallasi, A.1
Cortright, D.N.2
Blum, C.A.3
Eid, S.R.4
-
3
-
-
58149200910
-
Transient receptor potential channels: Targeting pain at the source
-
Patapoutian A, Tate S, Woolf CJ. Transient receptor potential channels: targeting pain at the source. Nat Rev Drug Discov 2009;8:55-68
-
(2009)
Nat Rev Drug Discov
, vol.8
, pp. 55-68
-
-
Patapoutian, A.1
Tate, S.2
Woolf, C.J.3
-
4
-
-
77956272001
-
International union of basic and clinical pharmacology LXXVI. current progress in the mammalian TRP ion channel family
-
Wu L-J, Sweet T-B, Clapham DE. International union of basic and clinical pharmacology. LXXVI. current progress in the mammalian TRP ion channel family. Pharmacol Rev 2010;62:381-404
-
(2010)
Pharmacol Rev
, vol.62
, pp. 381-404
-
-
Wu, L.-J.1
Sweet, T.-B.2
Clapham, D.E.3
-
5
-
-
0026083277
-
Molecular target size of the vanilloid (capsaicin) receptor in pig dorsal root ganglia
-
Szallasi A, Blumberg PM. Molecular target size of the vanilloid (capsaicin) receptor in pig dorsal root ganglia. Life Sci 1991;48(19):1867-9
-
(1991)
Life Sci
, vol.48
, Issue.19
, pp. 1867-1869
-
-
Szallasi, A.1
Blumberg, P.M.2
-
6
-
-
2942597685
-
Identification of a tetramerization domain in the C terminus of the vanilloid receptor
-
DOI 10.1523/JNEUROSCI.0202-04.2004
-
Garcia-Sanz V, Fernandez-Carvajal A, Marenilla-Palao C, et al. Identification of a tetramerization doamin in the C-terminus of the vanilloid receptor. J Neurosci 2004;24:5307-14 (Pubitemid 38747671)
-
(2004)
Journal of Neuroscience
, vol.24
, Issue.23
, pp. 5307-5314
-
-
Garcia-Sanz, N.1
Fernandez-Carvajal, A.2
Morenilla-Palao, C.3
Planells-Cases, R.4
Fajardo-Sanchez, E.5
Fernandez-Ballester, G.6
Ferrer-Montiel, A.7
-
7
-
-
24144490391
-
Extensive co-localization and heteromultimer formation of the vanilloid receptor-like protein TRPV2 and the capsaicin receptor TRPV1 in the adult rat cerebral cortex
-
DOI 10.1111/j.1460-9568.2005.04270.x
-
Liapi A, Wood JN. Extensive colocalization and heteromultimer formation of the vanilloid receptor-like protein TRPV2 and the capsaicin receptor TRPV1 in the adult rat cerebral cortex. Eur J Neurosci 2005;22:825-34 (Pubitemid 41243324)
-
(2005)
European Journal of Neuroscience
, vol.22
, Issue.4
, pp. 825-834
-
-
Liapi, A.1
Wood, J.N.2
-
8
-
-
0032970173
-
Vanilloid (Capsaicin) receptors and mechanisms
-
Szallasi A, Blumberg PM. Vanilloid (Capsaicin) receptors and mechanisms. Pharmacol Rev 1999;51:159-212
-
(1999)
Pharmacol Rev
, vol.51
, pp. 159-212
-
-
Szallasi, A.1
Blumberg, P.M.2
-
10
-
-
0043209362
-
ThermoTRP channels and beyond: Mechanisms of temperature sensation
-
DOI 10.1038/nrn1141
-
Patapoutian A, Peier AM, Story GM, Viswanath V. ThermoTRP channels and beyond: mechanisms of temperature sensation. Nat Rev Neurosci 2003;4:529-39 (Pubitemid 37271364)
-
(2003)
Nature Reviews Neuroscience
, vol.4
, Issue.7
, pp. 529-539
-
-
Patapoutian, A.1
Peier, A.M.2
Story, G.M.3
Viswanath, V.4
-
11
-
-
0037443098
-
Functional role of C-terminal cytoplasmic tail of rat vanilloid receptor 1
-
Vlachova V, Teisinger J, Susankova K, et al. Functional role of C-terminal cytoplasmic tail of rat vanilloid receptor 1. J Neurosci 2003;23:1340-50 (Pubitemid 36258912)
-
(2003)
Journal of Neuroscience
, vol.23
, Issue.4
, pp. 1340-1350
-
-
Vlachova, V.1
Teisinger, J.2
Susankova, K.3
Lyfenko, A.4
Ettrich, R.5
Vyklicky, L.6
-
12
-
-
79960580198
-
Modular thermal sensors in temperature-gated transient receptor potential (TRP) channels
-
Yao J, Liu B, Qin F. Modular thermal sensors in temperature-gated transient receptor potential (TRP) channels. Proc Natl Acad Sci USA 2011;108:11109-14
-
(2011)
Proc Natl Acad Sci USA
, vol.108
, pp. 11109-11114
-
-
Yao, J.1
Liu, B.2
Qin, F.3
-
13
-
-
33846807748
-
Transient receptor potential cation channels in disease
-
DOI 10.1152/physrev.00021.2006
-
Nilius B, Owsianik G, Voets T, Peters JA. Transient receptor potential cation channels in disease. Physiol Rev 2007;87:165-217 (Pubitemid 46207713)
-
(2007)
Physiological Reviews
, vol.87
, Issue.1
, pp. 165-217
-
-
Nilius, B.1
Owsianik, G.2
Voets, T.3
Peters, J.A.4
-
14
-
-
84872663547
-
A gain-of-function mutation in TRPA1 causes episodic familial pain syndrome
-
Kremeyer B, Lopera F, Cox JJ, et al. A gain-of-function mutation in TRPA1 causes episodic familial pain syndrome. Neuron 2010;66:871-80
-
(2010)
Neuron
, vol.66
, pp. 871-880
-
-
Kremeyer, B.1
Lopera, F.2
Cox, J.J.3
-
15
-
-
83755163025
-
SNP variant within the vanilloid TRPV1 and TRPV3 receptor genes are associated with migraine in the Spanish population
-
Carreno O, Corominas R, Fernandez-Morales J, et al. SNP variant within the vanilloid TRPV1 and TRPV3 receptor genes are associated with migraine in the Spanish population. Am J Med Genet B Neurophychiatr Genet 2012;159B:94-103
-
(2012)
Am J Med Genet B Neurophychiatr Genet
, vol.159 B
, pp. 94-103
-
-
Carreno, O.1
Corominas, R.2
Fernandez-Morales, J.3
-
17
-
-
0034926291
-
The vanilloid receptor: A molecular gateway to the pain pathway
-
DOI 10.1146/annurev.neuro.24.1.487
-
Caterina MJ, Julius D. The vanilloid receptor: a molecular gateway to the pain pathway. Annu Rev Neurosci 2001;24:487-517 (Pubitemid 32695237)
-
(2001)
Annual Review of Neuroscience
, vol.24
, pp. 487-517
-
-
Caterina, M.J.1
Julius, D.2
-
18
-
-
0034646740
-
Impaired nociception and pain sensation in mice lacking the capsaicin receptor
-
DOI 10.1126/science.288.5464.306
-
Caterina MJ, Leffler A, Malmberg AB, et al. Impaired nociception and pain sensation in mice lacking the capsaicin receptor. Science 2000;288:306-13 (Pubitemid 30226186)
-
(2000)
Science
, vol.288
, Issue.5464
, pp. 306-313
-
-
Caterina, M.J.1
Leffler, A.2
Malmberg, A.B.3
Martin, W.J.4
Trafton, J.5
Petersen-Zeitz, K.R.6
Koltzenburg, M.7
Basbaum, A.I.8
Julius, D.9
-
19
-
-
0034636441
-
Vanilloid receptor-1 is essential for inflammatory thermal hyperalgesia
-
DOI 10.1038/35012076
-
Davis JB, Gray J, Gunthorpe MJ, et al. Vanilloid receptor-1 is essential for inflammatory thermal hyperalgesia. Nature 2000;405:183-7 (Pubitemid 30313536)
-
(2000)
Nature
, vol.405
, Issue.6783
, pp. 183-187
-
-
Davis, J.B.1
Gray, J.2
Gunthorpe, M.J.3
Hatcher, J.P.4
Davey, P.T.5
Overend, P.6
Harries, M.H.7
Latcham, J.8
Clapham, C.9
Atkinson, K.10
Hughes, S.A.11
Rance, K.12
Grau, E.13
Harper, A.J.14
Pugh, P.L.15
Rogers, D.C.16
Bingham, S.17
Randall, A.18
Sheardown, S.A.19
-
20
-
-
34249990908
-
RNA interference-mediated knock-down of transient receptor potential vanilloid 1 prevents forepaw inflammatory hyperalgesia in rat
-
DOI 10.1111/j.1460-9568.2007.05584.x
-
Kasama S, Kawakubo M, Suzuki T, et al. RNA interference-mediated knock-down of transient receptor potential vanilloid 1 prevents forepaw inflammatory hyperalgesia in rat. Eur J Neurosci 2007;25:2956-63 (Pubitemid 46888823)
-
(2007)
European Journal of Neuroscience
, vol.25
, Issue.10
, pp. 2956-2963
-
-
Kasama, S.1
Kawakubo, M.2
Suzuki, T.3
Nishizawa, T.4
Ishida, A.5
Nakayama, J.6
-
21
-
-
33845343959
-
Antinociceptive effect of antisense oligonucleotides against the vanilloid receptor VR1/TRPV1
-
DOI 10.1016/j.neuint.2006.08.017, PII S0197018606002804
-
Christoph T, Gillen C, Mika J, et al. Antinociceptive effect of antisense oligonucleotides against the vanilloid receptor VR1/TRPV1. Neurochem Int 2007;50:281-90 (Pubitemid 44879686)
-
(2007)
Neurochemistry International
, vol.50
, Issue.1
, pp. 281-290
-
-
Christoph, T.1
Gillen, C.2
Mika, J.3
Grunweller, A.4
Schafer, M.K.-H.5
Schiene, K.6
Frank, R.7
Jostock, R.8
Bahrenberg, G.9
Weihe, E.10
Erdmann, V.A.11
Kurreck, J.12
-
22
-
-
38549118896
-
Capsaicin (TRPV1 agonist) therapy for pain relief: Farewell or revival?
-
DOI 10.1097/AJP.0b013e318158ed9e, PII 0000250820080200000009
-
Knotkova H, Pappagallo M, Szallasi A. Capsaicin (TRPV1 Agonist) therapy for pain relief: farewell or revival? Clin J Pain 2008;24:142-54 (Pubitemid 351156516)
-
(2008)
Clinical Journal of Pain
, vol.24
, Issue.2
, pp. 142-154
-
-
Knotkova, H.1
Pappagallo, M.2
Szallasi, A.3
-
23
-
-
80052216483
-
The vanilloid agonist resiniferatoxin for interventional-based pain control
-
Iadarola MJ, Mannes AJ. The vanilloid agonist resiniferatoxin for interventional-based pain control. Curr Top Med Chem 2011;11:2171-9
-
(2011)
Curr Top Med Chem
, vol.11
, pp. 2171-2179
-
-
Iadarola, M.J.1
Mannes, A.J.2
-
25
-
-
39449102203
-
Peripheral TRPV1 receptors as targets for drug development: New molecules and mechanisms
-
DOI 10.2174/138161208783330754
-
Gunthorpe MJ, Szallasi A. Peripheral TRPV1 receptors as targets for drugdevelopment: new molecules and mechanisms. Curr Pharm Des 2008;14:32-41 (Pubitemid 351266982)
-
(2008)
Current Pharmaceutical Design
, vol.14
, Issue.1
, pp. 32-41
-
-
Gunthorpe, M.J.1
Szallasi, A.2
-
27
-
-
84862277609
-
TRP channels as therapeutic targets in airway disorders: A patent review
-
[in press]
-
Preti D, Szallasi A, Patacchini R. TRP channels as therapeutic targets in airway disorders: a patent review. Exp Opin Ther Pat 2012;22:663-695. [in press]
-
(2012)
Exp Opin Ther Pat
, vol.22
, pp. 663-695
-
-
Preti, D.1
Szallasi, A.2
Patacchini, R.3
-
28
-
-
84872672964
-
-
Available from: http://www.xention.com/overactive-bladder
-
-
-
-
29
-
-
0001926637
-
Desensitization of sensory nerve endings
-
Jancso N, Jancso A. Desensitization of sensory nerve endings. Kiserletes Orvostudomany 1949;2(2 Suppl):15
-
(1949)
Kiserletes Orvostudomany
, vol.2
, Issue.2 SUPPL.
, pp. 15
-
-
Jancso, N.1
Jancso, A.2
-
30
-
-
0014128266
-
Direct evidence for neurogenic inflammation and its prevention by denervation and by pretreatment with capsaicin
-
Jancso N, Jancso-Gabor A, Szolcsanyi J. Direct evidence for neurogenic inflammation and its prevention by denervation and by pretreatment with capsaicin. Br J Pharmacol Chemother 1967;31:138-51
-
(1967)
Br J Pharmacol Chemother
, vol.31
, pp. 138-151
-
-
Jancso, N.1
Jancso-Gabor, A.2
Szolcsanyi, J.3
-
31
-
-
0017720392
-
Pharmacologically induced selective degeneration of chemosensitive primary sensory neurones
-
Jancso G, Kiraly E, Jancso-Gabor A. Pharmacologically induced selective degeneration of chemosensitive primary sensory neurones. Nature 1977;270:741-3 (Pubitemid 8239254)
-
(1977)
Nature
, vol.270
, Issue.5639
, pp. 741-743
-
-
Jancso, G.1
Kiraly, E.2
Jancso Gabor, A.3
-
33
-
-
0030307629
-
Vanilloid-sensitive neurons: A fundamental subdivision of the peripheral nervous system
-
Szallasi A. Vanilloid-sensitive neurons: a fundamental subdivision of the peripheral nervous system. J Peripher Nerv Syst 1996;1:6-18 (Pubitemid 126674016)
-
(1996)
Journal of the Peripheral Nervous System
, vol.1
, Issue.1
, pp. 6-18
-
-
Szallasi, A.1
-
34
-
-
0026089616
-
Topical capsaicin in the treatment of painful diabetic neuropathy
-
Levy DM, Abraham RR, Tomlinson DR. Topical capsaicin in the treatment of painful diabetic neuropathy. N Engl J Med 1991;324:776-7
-
(1991)
N Engl J Med
, vol.324
, pp. 776-777
-
-
Levy, D.M.1
Abraham, R.R.2
Tomlinson, D.R.3
-
35
-
-
68149094343
-
NGX-4010, a high-concentration capsaicin dermal patch for lasting relief of peripheral neuropathic pain
-
Noto C, Pappagallo M, Szallasi A. NGX-4010, a high-concentration capsaicin dermal patch for lasting relief of peripheral neuropathic pain. Curr Opin Investig Drugs 2009;10:702-10
-
(2009)
Curr Opin Investig Drugs
, vol.10
, pp. 702-710
-
-
Noto, C.1
Pappagallo, M.2
Szallasi, A.3
-
36
-
-
77952743084
-
A randomized, controlled, open-label study of the long-term effects of NGX-4010, a high-concentration capsaicin patch, on epidermal nerve fiber density and sensory function in healthy volunteers
-
Kennedy WR, Vanhove GF, Lu SP, et al. A randomized, controlled, open-label study of the long-term effects of NGX-4010, a high-concentration capsaicin patch, on epidermal nerve fiber density and sensory function in healthy volunteers. J Pain 2010;11:579-87
-
(2010)
J Pain
, vol.11
, pp. 579-587
-
-
Kennedy, W.R.1
Vanhove, G.F.2
Lu, S.P.3
-
37
-
-
77953090128
-
Long-term safety of NGX-4010, a high-concentration capsaicin patch, in patients with peripheral neuropathic pain
-
Simpson DM, Gazda S, Brown S, et al. Long-term safety of NGX-4010, a high-concentration capsaicin patch, in patients with peripheral neuropathic pain. J Pain Symptom Manage 2010;39:1053-64
-
(2010)
J Pain Symptom Manage
, vol.39
, pp. 1053-1064
-
-
Simpson, D.M.1
Gazda, S.2
Brown, S.3
-
39
-
-
84872650749
-
-
http://www.clinicaltrial.gov/ct2/show/NCT01228838?term= NCT01228838&rank=1
-
Neurogesx company website. Clinical trial Number (NCT01228838). Available from: http://www.neurogesx.com/c204-clinical-trial.http://www.clinicaltrial. gov/ct2/show/NCT01228838?term=NCT01228838&rank=1
-
Neurogesx Company Website. Clinical Trial Number (NCT01228838)
-
-
-
40
-
-
80051574246
-
Efficacy, safety, and tolerability of NGX-4010, capsaicin 8% patch, in an open-label study of patients with peripheral neuropathic pain
-
Webster LR, Peppin JF, Murphy FT, et al. Efficacy, safety, and tolerability of NGX-4010, capsaicin 8% patch, in an open-label study of patients with peripheral neuropathic pain. Diabetes Res Clin Pract 2011;93:187-97
-
(2011)
Diabetes Res Clin Pract
, vol.93
, pp. 187-197
-
-
Webster, L.R.1
Peppin, J.F.2
Murphy, F.T.3
-
41
-
-
0024382437
-
Resiniferatoxin, a phorbol-related diterpene, acts as an ultrapotent analog of capsaicin, the irritant constituent in red pepper
-
DOI 10.1016/0306-4522(89)90269-8
-
Szallasi A, Blumberg PM. Resiniferatoxin, a phorbol-related diterpene, acts as an ultrapotent analog of capsaicin, the irritant constituent in red pepper. Neuroscience 1989;30:515-20 (Pubitemid 19168499)
-
(1989)
Neuroscience
, vol.30
, Issue.2
, pp. 515-520
-
-
Szallasi, A.1
Blumberg, P.M.2
-
42
-
-
0025224503
-
Resiniferatoxin, an ultrapotent selective modulator of capsaicin-sensitive primary sensory neurons
-
Szolcsanyi J, Szallasi A, Szallasi Z, et al. Resiniferatoxin, an ultrapotent selective modulator of capsaicin-sensitive primary sensory neurons. J Pharmacol Exp Ther 1990;255:923-8
-
(1990)
J Pharmacol Exp Ther
, vol.255
, pp. 923-928
-
-
Szolcsanyi, J.1
Szallasi, A.2
Szallasi, Z.3
-
43
-
-
80052223776
-
Therapeutic targeting of TRPV1 by resiniferatoxin, from preclinical studies to clinical trials
-
Kissin I, Szallasi A. Therapeutic targeting of TRPV1 by resiniferatoxin, from preclinical studies to clinical trials. Curr Top Med Chem 2011;11:2159-70
-
(2011)
Curr Top Med Chem
, vol.11
, pp. 2159-2170
-
-
Kissin, I.1
Szallasi, A.2
-
44
-
-
49849104617
-
Vanilloid-induced conduction analgesia, selective, long-lasting, dose-dependent, with a low level of potential neurotoxicity
-
Kissin I. Vanilloid-induced conduction analgesia, selective, long-lasting, dose-dependent, with a low level of potential neurotoxicity. Anesth Analg 2008;107:261-71
-
(2008)
Anesth Analg
, vol.107
, pp. 261-271
-
-
Kissin, I.1
-
45
-
-
70349272715
-
Selective targeting of TRPV1 expressing sensory nerve terminals in the spinal cord for long lasting analgesia
-
Jeffrey JA, Yu SQ, Sikard P, et al. Selective targeting of TRPV1 expressing sensory nerve terminals in the spinal cord for long lasting analgesia. PLoS ONE 2009;4:7021-5
-
(2009)
PLoS ONE
, vol.4
, pp. 7021-7025
-
-
Jeffrey, J.A.1
Yu, S.Q.2
Sikard, P.3
-
46
-
-
0035128558
-
Capsaicin inhibits activation of voltage-gated sodium currents in capsaicin-sensitive trigeminal ganglion neurons
-
Liu L, Oortgiesen AM, Simon SA. Capsaicin inhibits activation of voltage-gated sodium currents in capsaicin-sensitive trigeminal ganglion neurons. J Neurophysiol 2001;85:745-58 (Pubitemid 32147776)
-
(2001)
Journal of Neurophysiology
, vol.85
, Issue.2
, pp. 745-758
-
-
Liu, L.1
Oortgiesen, M.2
Li, L.3
Simon, S.A.4
-
47
-
-
14544296132
-
Perineural resiniferatoxin prevents hyperalgesia in a rat model of postoperative of pain
-
DOI 10.1213/01.ANE.0000143570.75908.7F
-
Kissin I, Davison N, Bradley EL Jr. Perineural resiniferatoxin prevents hyperalgesia in a model of postoperative pain. Anesth Analg 2005;10:774-80 (Pubitemid 40300076)
-
(2005)
Anesthesia and Analgesia
, vol.100
, Issue.3
, pp. 774-780
-
-
Kissin, I.1
Davison, N.2
Bradley Jr., E.L.3
-
48
-
-
0036235474
-
Selective and long-lasting neural blockade with resiniferatoxin prevents inflammatory pain hypersensitivity
-
Kissin I, Bright CA, Bradley EL Jr. Selective and long-lasting blockade with resiniferatoxin prevents inflammatory pain hypersensitivity. Anesth Analg 2002;94:1253-8 (Pubitemid 34441846)
-
(2002)
Anesthesia and Analgesia
, vol.94
, Issue.5
, pp. 1253-1258
-
-
Kissin, I.1
Bright, C.A.2
Bradley Jr., E.L.3
-
49
-
-
0038161227
-
Peripherally induced resiniferatoxin analgesia
-
DOI 10.1016/S0304-3959(03)00009-5
-
Neubert JK, Laszlo K, Jun J, et al. Peripherally induced resiniferatoxin analgesia. Pain 2003;104:219-28 (Pubitemid 36835891)
-
(2003)
Pain
, vol.104
, Issue.1-2
, pp. 219-228
-
-
Neubert, J.K.1
Karai, L.2
Jun, J.H.3
Kim, H.-S.4
Olah, Z.5
Iadarola, M.J.6
-
50
-
-
39449112965
-
Perineural resiniferatoxin selectively inhibits inflammatory hyperalgesia
-
Neubert JK, Mannes AJ, Laszlo K, et al. Perineural resiniferatoxin selectively inhibits inflammatory hyperalgesia. Mol Pain 2008;4:1-10
-
(2008)
Mol Pain
, vol.4
, pp. 1-10
-
-
Neubert, J.K.1
Mannes, A.J.2
Laszlo, K.3
-
51
-
-
34247465445
-
Perineural resiniferatoxin prevents the development of hyperalgesia produced by loose ligation of the sciatic nerve in rats
-
DOI 10.1213/01.ane.0000260296.01813.62, PII 0000053920070500000037
-
Kissin I, Freitas CF, Bradley EL Jr. Preineural resiniferatoxin prevents the development of hyperalgesia produced by loose ligation of the sciatic nerve in rats. Anesth Analg 2007;104:1210-16 (Pubitemid 46649947)
-
(2007)
Anesthesia and Analgesia
, vol.104
, Issue.5
, pp. 1210-1216
-
-
Kissin, I.1
Freitas, C.F.2
Bradley Jr., E.L.3
-
52
-
-
27444431571
-
The effects of intraarticular resiniferatoxin in experimental knee-joint arthritis
-
DOI 10.1213/01.ANE.0000180998.29890.B0
-
Kissin EY, Freitas CF, Kissin I. The effects of intraarticular resiniferatoxin in experimental knee-joint arthritis. Anesth Analg 2005;101:1433-9 (Pubitemid 41531884)
-
(2005)
Anesthesia and Analgesia
, vol.101
, Issue.5
, pp. 1433-1439
-
-
Kissin, E.Y.1
Freitas, C.F.2
Kissin, I.3
-
53
-
-
85047690839
-
Deletion of vanilloid receptor 1-expressing primary afferent neurons for pain control
-
DOI 10.1172/JCI200420449
-
Karai L, Brown DC, Mannes AJ, et al. Deletion of the vanilloid receptor 1-expressing primary afferent neurons for pain control. J Clin Invest 2004;113:1344-52 (Pubitemid 39069933)
-
(2004)
Journal of Clinical Investigation
, vol.113
, Issue.9
, pp. 1344-1352
-
-
Karai, L.1
Brown, D.C.2
Mannes, A.J.3
Connelly, S.T.4
Brown, J.5
Gandal, M.6
Wellisch, O.M.7
Neubert, J.K.8
Olah, Z.9
Iadarola, M.J.10
-
54
-
-
24744460256
-
Peripheral targeting of the trigeminal ganglia via the infraorbital foramen as a therapeutic strategy
-
Neubert JK, Mannes AJ, Keller J, et al. Peripheral targeting of the trigeminal ganglia via the infraorbital foramen as a therapeutic strategy. Brain Res Brain Res Protoc 2005;15:119-25
-
(2005)
Brain Res Brain Res Protoc
, vol.15
, pp. 119-125
-
-
Neubert, J.K.1
Mannes, A.J.2
Keller, J.3
-
55
-
-
27644551317
-
Physiologic and antinociceptive effects of intrathecal resiniferatoxin in a canine bone cancer model
-
DOI 10.1097/00000542-200511000-00020
-
Brown DC, Iadarola MJ, Perkowski SZ, et al. Physiologic and antinociceptive effects of intrathecal resiniferatoxin in a canine bone cancer model. Anesthesiology 2005;103:1052-9 (Pubitemid 41552061)
-
(2005)
Anesthesiology
, vol.103
, Issue.5
, pp. 1052-1059
-
-
Brown, D.C.1
Iadarola, M.J.2
Perkowski, S.Z.3
Erin, H.4
Shofer, F.5
Laszlo, K.J.6
Olah, Z.7
Mannes, A.J.8
-
56
-
-
77952099949
-
Prolonged analgesic response of cornea to topical resiniferatoxin, a potent TRPV1 agonist
-
Bates BD, Michell K, Keller JM, et al. Prolonged analgesic response of cornea to topical resiniferatoxin, a potent TRPV1 agonist. Pain 2010;49:522-8
-
(2010)
Pain
, vol.49
, pp. 522-528
-
-
Bates, B.D.1
Michell, K.2
Keller, J.M.3
-
57
-
-
40749097682
-
Advances in the design and therapeutic use of capsaicin receptor TRPV1 agonists and antagonists
-
DOI 10.1517/13543776.18.2.159
-
Gharat L, Szallasi A. Advances in the design and therapeutic use of capsaicin receptor TRPV1 agonists and antagonists. Exp Opin Ther Patents 2008;18:159-209 (Pubitemid 351377054)
-
(2008)
Expert Opinion on Therapeutic Patents
, vol.18
, Issue.2
, pp. 159-209
-
-
Gharat, L.A.1
Szallasi, A.2
-
59
-
-
34848820269
-
The effects of the TRPV1 antagonist SB-705498 on TRPV1 receptor-mediated activity and inflammatory hyperalgesia in humans
-
DOI 10.1016/j.pain.2007.06.006, PII S0304395907003089
-
Chizh BA, O'Donnell MB, Napolitano A, et al. The effects of the TRPV1 antagonist SB-705498 on TRPV1 receptor-mediated activity and inflammatory hyperalgesia in humans. Pain 2007;132:132-41 (Pubitemid 47494566)
-
(2007)
Pain
, vol.132
, Issue.1-2
, pp. 132-141
-
-
Chizh, B.A.1
O'Donnell, M.B.2
Napolitano, A.3
Wang, J.4
Brooke, A.C.5
Aylott, M.C.6
Bullman, J.N.7
Gray, E.J.8
Lai, R.Y.9
Williams, P.M.10
Appleby, J.M.11
-
60
-
-
33646677987
-
Discovery of SB-705498: A potent, selective and orally bioavailable TRPV1 antagonist suitable for clinical development
-
DOI 10.1016/j.bmcl.2006.03.030, PII S0960894X06003271
-
Rami HK, Thompson M, Stemp G, et al. Discovery of SB-705498: a potent, selective and orally bioavailable TRPV1 antagonists suitable for clinical development. Bioorg Med Chem Lett 2006;16:3287-91 (Pubitemid 43732339)
-
(2006)
Bioorganic and Medicinal Chemistry Letters
, vol.16
, Issue.12
, pp. 3287-3291
-
-
Rami, H.K.1
Thompson, M.2
Stemp, G.3
Fell, S.4
Jerman, J.C.5
Stevens, A.J.6
Smart, D.7
Sargent, B.8
Sanderson, D.9
Randall, A.D.10
Gunthorpe, M.J.11
Davis, J.B.12
-
61
-
-
77954090059
-
Effect of the transient receptor potential vanilloid 1 (TRPV1) antagonist compounds SB-705498, BCTC and AMG9810 in rat models of thermal hyperalgesia measured with an increasing temperature water bath
-
Tekus V, Bolcskei K, Kiss-Varga A, et al. Effect of the transient receptor potential vanilloid 1 (TRPV1) antagonist compounds SB-705498, BCTC and AMG9810 in rat models of thermal hyperalgesia measured with an increasing temperature water bath. Eur J Pharmacol 2010;641:135-41
-
(2010)
Eur J Pharmacol
, vol.641
, pp. 135-141
-
-
Tekus, V.1
Bolcskei, K.2
Kiss-Varga, A.3
-
62
-
-
79954617292
-
Randomized clinical trial: The efficacy of the transient receptor potential vanilloid 1 antagonist AZD1386 in human oesophageal pain
-
Krarup AL, Ny L, Astrand M, et al. Randomized clinical trial: the efficacy of the transient receptor potential vanilloid 1 antagonist AZD1386 in human oesophageal pain. Aliment Pharmacol Ther 2011;33:1113-22
-
(2011)
Aliment Pharmacol Ther
, vol.33
, pp. 1113-1122
-
-
Krarup, A.L.1
Ny, L.2
Astrand, M.3
-
63
-
-
80052237527
-
Therapeutic targeting of TRP channels: The TR (i)P to pain relief
-
Eid SR. Therapeutic targeting of TRP channels: the TR(i)P to pain relief. Curr Top Med Chem 2011;11:2118-30
-
(2011)
Curr Top Med Chem
, vol.11
, pp. 2118-2130
-
-
Eid, S.R.1
-
64
-
-
84872647357
-
-
Eid SR. In: 2009.Available from:http://www.arrowheadpublishers.com/ conferences/pain-therapeutics-2009/agenda/Summit
-
(2009)
-
-
Eid, S.R.1
-
65
-
-
84872670592
-
-
Available from: http://www.pharmeste.com/include/PHE377.pdf
-
-
-
-
67
-
-
0014746672
-
Irreversible impairment of thermoregulation induced by capsaicin and similar pungent substances in the rats and guinea pigs
-
Jancso-Gabor A, Szolcsanyi J, Jancso N. Irreversible impairment of thermoregulation induced by capsaicin and similar pungent substances in the rats and guinea pigs. J Physiol 1970;206:495-507
-
(1970)
J Physiol
, vol.206
, pp. 495-507
-
-
Jancso-Gabor, A.1
Szolcsanyi, J.2
Jancso, N.3
-
68
-
-
0021737076
-
Capsaicin and central control of thermoregulation
-
DOI 10.1016/0163-7258(84)90041-X
-
Hori T. Capsaicin and central control of thermoregulation. Pharmacol Ther 1984;26:389-416 (Pubitemid 15143740)
-
(1984)
Pharmacology and Therapeutics
, vol.26
, Issue.3
, pp. 389-416
-
-
Hori, T.1
-
69
-
-
0015214557
-
Mitochondrial changes in preoptic neurons after capsaicin desensitization of the hypothalamic thermodetectors in the rat
-
Szolcsanyi J, Joo F, Jancso-Gabor A. Mitochondrial changes in preoptic neurons after capsaicin desensitization of the hypothalamic thermodetectors in the rat. Nature 1971;229:116-17
-
(1971)
Nature
, vol.229
, pp. 116-117
-
-
Szolcsanyi, J.1
Joo, F.2
Jancso-Gabor, A.3
-
70
-
-
34047118624
-
The vanilloid receptor TRPV1 is tonically activated in vivo and involved in body temperature regulation
-
DOI 10.1523/JNEUROSCI.4833-06.2007
-
Gavva NR, Bannon AW, Surapaneni S, et al. The vanilloid receptor TRPV1 is tonically activated in vivo and involved in body temperature regulation. J Neurosci 2007;27:3366-74 (Pubitemid 46515121)
-
(2007)
Journal of Neuroscience
, vol.27
, Issue.13
, pp. 3366-3374
-
-
Gavva, N.R.1
Bannon, A.W.2
Surapaneni, S.3
Hovland Jr., D.N.4
Lehto, S.G.5
Gore, A.6
Juan, T.7
Deng, H.8
Han, B.9
Klionsky, L.10
Kuang, R.11
Le, A.12
Tamir, R.13
Wang, J.14
Youngblood, B.15
Zhu, D.16
Norman, M.H.17
Magal, E.18
Treanor, J.J.S.19
Louis, J.-C.20
more..
-
71
-
-
41749117999
-
Pharmacological blockade of the vanilloid receptor TRPV1 elicits marked hyperthermia in humans
-
Gavva NR, Treanor JJ, Garami A, et al. Pharmacological blockade of the vanilloid receptor TRPV1 elicits marked hyperthermia in humans. Pain 2008;136:202-10
-
(2008)
Pain
, vol.136
, pp. 202-210
-
-
Gavva, N.R.1
Treanor, J.J.2
Garami, A.3
-
72
-
-
34548825160
-
Repeated administration of vanilloid receptor TRPV1 antagonists attenuates hyperthermia elicited by TRPV1 blockade
-
DOI 10.1124/jpet.107.125674
-
Gavva NR, Bannon AW, Hovland DN Jr, et al. Repeated administration of vanilloid receptor TRPV1 antagonists attenuates hyperthermia elicited by TRPV1 blockade. J Pharmacol Exp Ther 2007;323:128-37 (Pubitemid 47443270)
-
(2007)
Journal of Pharmacology and Experimental Therapeutics
, vol.323
, Issue.1
, pp. 128-137
-
-
Gavva, N.R.1
Bannon, A.W.2
Hovland Jr., D.N.3
Lehto, S.G.4
Klionsky, L.5
Surapaneni, S.6
Immke, D.C.7
Henley, C.8
Arik, L.9
Bak, A.10
Davis, J.11
Ernst, N.12
Hever, G.13
Kuang, R.14
Shi, L.15
Tamir, R.16
Wang, J.17
Wang, W.18
Zajic, G.19
Zhu, D.20
Norman, M.H.21
Louis, J.-C.22
Magal, E.23
Treanor, J.J.S.24
more..
-
73
-
-
14844309685
-
Attenuated fever response in mice lacking TRPV1
-
DOI 10.1016/j.neulet.2004.12.007
-
Iida T, Shimizu I, Nealen ML, et al. Attenuated fever response in mice lacking TRPV1. Neurosci Lett 2005;378:28-33 (Pubitemid 40341937)
-
(2005)
Neuroscience Letters
, vol.378
, Issue.1
, pp. 28-33
-
-
Iida, T.1
Shimizu, I.2
Nealen, M.L.3
Campbell, A.4
Caterina, M.5
-
74
-
-
70349659983
-
The transient receptor potential vanilloid-1 channel in thermoregulation: A thermosensor it is not
-
Romanovsky AA, Almeida MC, Garami A, et al. The transient receptor potential vanilloid-1 channel in thermoregulation: a thermosensor it is not. Pharmacol Rev 2009;61:228-61
-
(2009)
Pharmacol Rev
, vol.61
, pp. 228-261
-
-
Romanovsky, A.A.1
Almeida, M.C.2
Garami, A.3
-
75
-
-
67649240813
-
Body-temperature maintenance as the predominant function of the vanilloid receptor TRPV1
-
Gavva NR. Body-temperature maintenance as the predominant function of the vanilloid receptor TRPV1. Trends Pharmacol Sci 2008;19:19-23
-
(2008)
Trends Pharmacol Sci
, vol.19
, pp. 19-23
-
-
Gavva, N.R.1
-
76
-
-
0021947967
-
Capsaicin impairs preoptic serotonin-sensitive structures mediating hypothermia in rats
-
Hajos M, Obal F Jr, Jancso G, Obal F. Capsaicin impairs preoptic serotonin-sensitive structures mediating hypothermia in rats. Neurosci Lett 1985;54:97-102 (Pubitemid 15126764)
-
(1985)
Neuroscience Letters
, vol.54
, Issue.1
, pp. 97-102
-
-
Hajos, M.1
Obal Jr., F.2
Jancso, G.3
Obal, F.4
-
77
-
-
33748680717
-
TRPV1 receptors in the CNS play a key role in broad-spectrum analgesia of TRPV1 antagonists
-
DOI 10.1523/JNEUROSCI.1246-06.2006
-
Cui M, Honore P, Zhong C, et al. TRPV1 receptors in the CNS play a key role in broad-spectrum analgesia of TRPV1 antagonists. J Neurosci 2006;26:9385-93 (Pubitemid 44396851)
-
(2006)
Journal of Neuroscience
, vol.26
, Issue.37
, pp. 9385-9393
-
-
Cui, M.1
Honore, P.2
Zhong, C.3
Gauvin, D.4
Mikusa, J.5
Hernandez, G.6
Chandran, P.7
Gomtsyan, A.8
Brown, B.9
Bayburt, E.K.10
Marsh, K.11
Bianchi, B.12
McDonald, H.13
Niforatos, W.14
Neelands, T.R.15
Moreland, R.B.16
Decker, M.W.17
Lee, C.-H.18
Sullivan, J.P.19
Faltynek, C.R.20
more..
-
78
-
-
45749092572
-
Antihyperalgesic effects of (R,E)-N-(2-hydroxy-2,3-dihydro-1H-inden-4-yl) - 3-(2-(piperidin-1-yl)-4-(trifluoromethyl)phenyl)-acrylamide (AMG8562), a novel transient receptor potential vanilloid type 1 modulator that does not cause hyperthermia in rats
-
DOI 10.1124/jpet.107.132233
-
Lehto SG, Tamir R, Deng H, et al. Antihyperalgesic effects of (R, E)-N-(2- hydroxy-2, 3-dihydro-1H-inden-4-yl)-3- (2-(piperidin-1-yl)-4- (trifluorom ethyl) phenyl)-acrylamide (AMG8562), a novel transient receptor potential vanilloid type 1 modulator that does not cause hyperthermia in rats. J Pharmacol Exp Ther 2008;326:218-29 (Pubitemid 351872146)
-
(2008)
Journal of Pharmacology and Experimental Therapeutics
, vol.326
, Issue.1
, pp. 218-229
-
-
Lehto, S.G.1
Tamir, R.2
Deng, H.3
Klionsky, L.4
Kuang, R.5
Le, A.6
Lee, D.7
Louis, J.-C.8
Magal, E.9
Manning, B.H.10
Rubino, J.11
Surapaneni, S.12
Tamayo, N.13
Wang, T.14
Wang, J.15
Wang, J.16
Wang, W.17
Youngblood, B.18
Zhang, M.19
Zhu, D.20
Norman, M.H.21
Gavva, N.R.22
more..
-
79
-
-
84055219327
-
Small molecule positive allosteric modulation of TRPV1 activation by vanilloids and acidic pH
-
Kaszas K, Keller JM, Coddou C, et al. Small molecule positive allosteric modulation of TRPV1 activation by vanilloids and acidic pH. J Pharmacol Exp Ther 2012;340:152-60
-
(2012)
J Pharmacol Exp Ther
, vol.340
, pp. 152-160
-
-
Kaszas, K.1
Keller, J.M.2
Coddou, C.3
-
81
-
-
77249125805
-
The paradoxical role of the transient receptor potential vanilloid 1 receptor in inflammation
-
Alawi K, Keeble J. The paradoxical role of the transient receptor potential vanilloid 1 receptor in inflammation. Pharmacol Ther 2010;125:181-91
-
(2010)
Pharmacol Ther
, vol.125
, pp. 181-191
-
-
Alawi, K.1
Keeble, J.2
-
82
-
-
84856084105
-
Aging reverses the role of the transient receptor potential vanilloid 1 channel in systemic inflammation from antiinflammatory to pro-inflammatory
-
Wanner SP, Garami A, Pakai E, et al. Aging reverses the role of the transient receptor potential vanilloid 1 channel in systemic inflammation from antiinflammatory to pro-inflammatory. Cell Cycle 2012;11:343-9
-
(2012)
Cell Cycle
, vol.11
, pp. 343-349
-
-
Wanner, S.P.1
Garami, A.2
Pakai, E.3
-
83
-
-
79955468809
-
Disruption of the transient receptor potential vanilloid 1 can affect survival, bacterial clearance, and cytokine gene expression during murine sepsis
-
Guptill V, Cui X, Khaibullina A, et al. Disruption of the transient receptor potential vanilloid 1 can affect survival, bacterial clearance, and cytokine gene expression during murine sepsis. Anesthesiology 2011;114:1190-9
-
(2011)
Anesthesiology
, vol.114
, pp. 1190-1199
-
-
Guptill, V.1
Cui, X.2
Khaibullina, A.3
-
84
-
-
35948961125
-
The transient receptor potential vanilloid 1 (TRPV1) receptor protects against the onset of sepsis after endotoxin
-
DOI 10.1096/fj.06-7460com
-
Clark N, Keeble J, Fernandes ES, et al. The transient receptor potential vanilloid 1 (TRPV1) protects against the onset of sepsis after endotoxin. FASEB J 2007;21:3747-55 (Pubitemid 350075162)
-
(2007)
FASEB Journal
, vol.21
, Issue.13
, pp. 3747-3755
-
-
Clark, N.1
Keeble, J.2
Fernandes, E.S.3
Starr, A.4
Liang, L.5
Sugden, D.6
De Winter, P.7
Brain, S.D.8
-
85
-
-
84857498688
-
TRPV1 antagonists may exacerbate sepsisin aged mice: Should we be nervous?
-
Quezado ZM, Szallasi A. TRPV1 antagonists may exacerbate sepsisin aged mice: should we be nervous? Cell Cycle 2012;11:647-8
-
(2012)
Cell Cycle
, vol.11
, pp. 647-648
-
-
Quezado, Z.M.1
Szallasi, A.2
-
86
-
-
84872671517
-
-
Available from: http://www.qutenza.com
-
-
-
-
87
-
-
38849118953
-
Adlea (ALGRX-4975), an injectable capsaicin (TRPV1 receptor agonist) formulation for longlasting pain relief
-
Remadevi R, Szallasi A. Adlea (ALGRX- 4975), an injectable capsaicin (TRPV1 receptor agonist) formulation for long lasting pain relief. IDrugs 2008;11:120-32 (Pubitemid 351196171)
-
(2008)
IDrugs
, vol.11
, Issue.2
, pp. 120-132
-
-
Remadevi, R.1
Szallisi, A.2
-
88
-
-
84872648431
-
-
Available from: http://www.bizjournals.com/sanfrancisco/stories/2010/01/ 11/story4.html
-
-
-
-
90
-
-
35148889475
-
Resiniferatoxin and botulinum toxin type A for treatment of lower urinary tract symptoms
-
DOI 10.1002/nau.20479
-
Cruz F, Dinis P. Resiniferatoxin and botulinum toxin type A for the treatment of lower urinary tract syndromes. Neurourol Urodyn 2007;26:920-7 (Pubitemid 47548229)
-
(2007)
Neurourology and Urodynamics
, vol.26
, Issue.6 SUPPL.
, pp. 920-927
-
-
Cruz, F.1
Dinis, P.2
-
91
-
-
28444467821
-
Analgesic effects of capsazepine and resiniferatoxin on bone cancer pain in mice
-
DOI 10.1016/j.neulet.2005.09.046, PII S0304394005011067
-
Menendez L, Juarez L, Garcia E, et al. Analgesic effects of capsazepine and resiniferatoxin on bone cancer pain in mice. Neurosci Lett 2006;393:70-3 (Pubitemid 41739656)
-
(2006)
Neuroscience Letters
, vol.393
, Issue.1
, pp. 70-73
-
-
Menendez, L.1
Juarez, L.2
Garcia, E.3
Garcia-Suarez, O.4
Hidalgo, A.5
Baamonde, A.6
-
92
-
-
44749085444
-
TRPV1 null mice are protected from diet-induced obesity
-
Motter AL, Ahern GP. TRPV1 null mice are protected from diet-induced obesity. FASEB J 2008;582:2257-62
-
(2008)
FASEB J
, vol.582
, pp. 2257-2262
-
-
Motter, A.L.1
Ahern, G.P.2
-
93
-
-
80052102101
-
Hyperactive when young, hypoactive and overweight when aged: Connecting the dots in the story about locomotor activity, body mass, and aging in trpv1 knockout mice
-
Wanner SP, Garami A, Romanovsky AA. Hyperactive when young, hypoactive and overweight when aged: connecting the dots in the story about locomotor activity, body mass, and aging in trpv1 knockout mice. Aging 2011;3:450-4
-
(2011)
Aging
, vol.3
, pp. 450-454
-
-
Wanner, S.P.1
Garami, A.2
Romanovsky, A.A.3
-
94
-
-
84872655817
-
-
Available from: http://www.podiatryarena.com/podiatry-forum/showthread. php?t.9707
-
-
-
-
95
-
-
4444292549
-
Reduced heat sensitivity and epidermal nerve fiber immunostaining following single applications of a high-concentration capsaicin patch
-
DOI 10.1016/j.pain.2004.07.017, PII S0304395904003446
-
Malmberg AB, Mizisin AP, Calcutt NA, et al. Reduced heat sensitivity and epidermal nerve fiber immunostaining following single applications of a high-concentration capsaicin patch. Pain 2004;111:360-7 (Pubitemid 39201158)
-
(2004)
Pain
, vol.111
, Issue.3
, pp. 360-367
-
-
Malmberg, A.B.1
Mizisin, A.P.2
Calcutt, N.A.3
Von Stein, T.4
Robbins, W.R.5
Bley, K.R.6
-
97
-
-
84865311080
-
An open-label pilot study of high-concentration capsaicin patch in painful HIV neuropathy
-
Simpson DM, Estanislaso L, Brwn SJ, Sampson J. An open-label pilot study of high-concentration capsaicin patch in painful HIV neuropathy. J Pain Symptom Manage 2008;12:1106-12
-
(2008)
J Pain Symptom Manage
, vol.12
, pp. 1106-1112
-
-
Simpson, D.M.1
Estanislaso, L.2
Brwn, S.J.3
Sampson, J.4
-
98
-
-
84872660145
-
-
NeurogesX Inc. Form 10-K. NeurogesX Inc. Form 10-K 2008 March 26 (neurogesx.com)
-
NeurogesX, Inc. Form 10-K. NeurogesX, Inc. Form 10-K 2008 March 26 (neurogesx.com)
-
-
-
-
99
-
-
77957671908
-
Effect of duration of postherpetic neuralgia on efficacy analyses in a multicenter, randomized, controlled study of NGX-4010, an 8% capsaicin patch evaluated for the treatment of postherpetic neuralgia
-
Webster LR, Tark M, Rauck R, et al. Effect of duration of postherpetic neuralgia on efficacy analyses in a multicenter, randomized, controlled study of NGX-4010, an 8% capsaicin patch evaluated for the treatment of postherpetic neuralgia. BMC Neurol 2010;10:92
-
(2010)
BMC Neurol
, vol.10
, pp. 92
-
-
Webster, L.R.1
Tark, M.2
Rauck, R.3
-
100
-
-
55549129906
-
NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia: A randomized, double-blind study
-
Backonfa M, Wallace MS, Blonsky ER, et al. NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia: a randomized, double-blind study. Lancet Neurol 2008;12:1106-12
-
(2008)
Lancet Neurol
, vol.12
, pp. 1106-1112
-
-
Backonfa, M.1
Wallace, M.S.2
Blonsky, E.R.3
-
101
-
-
78651257952
-
A multicenter, randomized, double-blind, controlled study of NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia
-
Irving GA, Backonja MM, Dunteman E, et al. A multicenter, randomized, double-blind, controlled study of NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia. Pain Med 2011;1:99-109
-
(2011)
Pain Med
, vol.1
, pp. 99-109
-
-
Irving, G.A.1
Backonja, M.M.2
Dunteman, E.3
-
102
-
-
46049111268
-
Controlled trial of high-concentration capsaicin patch for treatment of painful HIV neuropathy
-
Simpson DM, Browen S, Tobias J. Controlled trial of high-concentration capsaicin patch for treatment of painful HIV neuropathy. Neurology 2008;28:2305-13
-
(2008)
Neurology
, vol.28
, pp. 2305-2313
-
-
Simpson, D.M.1
Browen, S.2
Tobias, J.3
|